article thumbnail

Cannabis laws in Japan: Is weed legal?

The Cannigma

In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes. The Tokyo Marijuana March has been held since 2001, though it’s a much more reserved and smoke-free event than its counterparts in many other countries.

Law 137
article thumbnail

SciSparc Announces Positive Topline Results For Proprietary Pain Management Compound In Pre-Clinical Study

Cannabis Law Report

(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UK Article: Why Don’t We Just… reschedule psilocybin?

Cannabis Law Report

Firstly, psychedelics are administered infrequently in controlled settings with up to only three treatments shown to produce long lasting benefits in clinical trials so far. It is extremely expensive (over £20,000 for one clinical trial), bureaucratic and incurs large time delays (up to one year). of charge on the NHS.

article thumbnail

Guest Post: Denmark’s pilot pharma trial attracts first-movers

Cannabis Law Report

They are learning quickly from the successes and failures in Canada’s legal medical cannabis program that has been active since 2001. The roadmap ahead includes clinical trials and more research in Denmark. Arundati Dandapani. Founder and CEO, . Generation1.ca. C) 613-890-7133. (T) T) @itadnura.

article thumbnail

UK: Tory MP Crispin Blunt At Loggerheads With The Home Office Over Psilocybin Research

Cannabis Law Report

A Home Office spokesperson said: “There is an established process for the development of medicines, which enables medicines including psilocybin to be developed, evaluated in clinical trials and licensed based on an assessment of their quality, safety and efficacy. Source: [link].

article thumbnail

Pushing Cannabis into Modern Healthcare

CannaTech

Canada has been at the forefront of shaping much of the rhetoric surrounding cannabis since 2001. Over time extended clinical trials will continue to map out the plant’s therapeutic effects, supporting it as an alternative medicine offering relief for a long list of conditions. Changing Cannabis Conversations Worldwide.

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.